Literature DB >> 26563486

Hip fractures in patients older than 75 years old: Retrospective analysis for prognostic factors.

Gökhan Karademir1, Yücel Bilgin2, Ali Erşen3, Gökhan Polat4, Mehmet I Buget5, Mehmet Demirel6, Halil Ibrahim Balcı7.   

Abstract

BACKGROUND: Proximal femoral fractures are often seen in older patients and are associated with high mortality. Introduction to old age population is latening due to advancements in medical sciences and increasing life expectancy.
OBJECTIVES: The aim of the study was to evaluate factors affecting mortality in patients above 75 years of age who had been operated because of proximal femur fractures. PATIENTS AND METHODS: Patients with age 75 and over who suffers from post-fall proximal femoral fracture who underwent surgery with one of following three methods (hemiarthroplasty, proximal femoral nail or total hip arthroplasty) were evaluated retrospectively. Effects on mortality were examined for factors such as type of surgery, type of anesthesia, preoperative ASA score (American Society of Anesthesiologists Score), need for intensive care, need for blood transfusion, operation waiting time and hospitalization duration. 115 patients who met inclusion criterion were included in the study out of 224 overall. 75 patients were women and 40 were males.
RESULTS: Mortality rate after first year was found to be 40%. Patients over 85 years old had higher rates of mortality (p = 0,0003) than respectively younger patients (75-85). Sex was found to have no impact on mortality (p = 0.5039). There was no statistically significant difference in terms ASA score (p = 0.1518). Order of applied surgical methods with mortality risk rates was found to be total hip arthroplasty > hemiarthroplasty > proximal femoral nail (p = 0.0003). Type of anesthesia, the use of cement during arthroplasty, operation waiting time and hospitalization duration was not directly related with mortality rate (type of anesthesia p = 0.63, the use of cement during arthroplasty p = 0.223, operation waiting time p = 0.5 and hospitalization duration p = 0.19).
CONCLUSIONS: Age is the primary risk factor on first year mortality in patients older than 75 years old with hip fractures. Addition to older age, more need to blood transfusions, and arthroplasty are other risk factors for first year mortality. It should be kept in mind that after 75 years old first year mortality may be higher if the patient is treated with arthroplasty.
Copyright © 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Affecting; Factors; Hip fracture; Mortality; Over 75 years of age; Prognostic; Proximal femoral fracture

Mesh:

Year:  2015        PMID: 26563486     DOI: 10.1016/j.ijsu.2015.11.009

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  10 in total

1.  Spinal anesthesia versus combined sciatic nerve/lumbar plexus nerve block in elderly patients undergoing total hip arthroplasty: a retrospective study.

Authors:  Mustafa Kaçmaz; Zeynep Yuksel Turhan
Journal:  Ann Saudi Med       Date:  2022-06-02       Impact factor: 1.707

2.  Risk factors for mortality in geriatric hip fractures: a compressional study of different surgical procedures in 785 consecutive patients.

Authors:  Ersin Ercin; M Gokhan Bilgili; Cihangir Sari; S Hakan Basaran; Bulent Tanriverdi; Erdem Edipoglu; K Mumtaz Celen; Halil Cetingok; Cemal Kural
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-08-31

3.  Age, Comorbidities and Fear of Fall: mortality predictors associated with fall-related fractures.

Authors:  Magdalini Velegraki; Petros Ioannou; Constantinos Tsioutis; Garyfalia S Persynaki; Emmanouil Pediaditis; Christos Koutserimpas; George Kontakis; Kalliopi Alpantaki; George Samonis; Symeon H Panagiotakis
Journal:  Maedica (Bucur)       Date:  2020-03

4.  Vitamin D Deficiency Is Highly Concomitant but Not Strong Risk Factor for Mortality in Patients Aged 50 Year and Older with Hip Fracture.

Authors:  Gyeong-Hak Lee; Jung-Won Lim; Yong-Gum Park; Yong-Chan Ha
Journal:  J Bone Metab       Date:  2015-11-30

Review 5.  General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis.

Authors:  Julia Van Waesberghe; Ana Stevanovic; Rolf Rossaint; Mark Coburn
Journal:  BMC Anesthesiol       Date:  2017-06-28       Impact factor: 2.217

6.  One-year mortality in displaced intracapsular hip fractures and associated risk: a report of Chinese-based fragility fracture registry.

Authors:  Simon Kwoon-Ho Chow; Jiang-Hui Qin; Ronald Man-Yeung Wong; Wai-Fan Yuen; Wai-Kit Ngai; Ning Tang; Chor-Yin Lam; Tak-Wing Lau; Kin-Bong Lee; Kwai Ming Siu; Sze-Hung Wong; Tracy Y Zhu; Wing-Hoi Cheung; Kwok-Sui Leung
Journal:  J Orthop Surg Res       Date:  2018-09-14       Impact factor: 2.359

7.  Comparison of combined lumbar and sacral plexus block with sedation versus general anaesthesia on postoperative outcomes in elderly patients undergoing hip fracture surgery (CLSB-HIPELD): study protocol for a prospective, multicentre, randomised controlled trial.

Authors:  Junfeng Zhang; Xiaofeng Wang; Hui Zhang; Zhuolin Shu; Wei Jiang
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

8.  Time-to-Incision for Hip Fractures in a Canadian Level-1 Trauma Centre: Are We Respecting the Guidelines?

Authors:  Antoine Denis; Julien Montreuil; Rudolf Reindl; Gregory K Berry; Edward J Harvey; Mitchell Bernstein
Journal:  Can Geriatr J       Date:  2022-03-02

9.  Mortality and Related Risk Factors of Fragile Hip Fracture.

Authors:  Pei-Wen Wang; Xue-Dong Yao; Hua-Feng Zhuang; Yi-Zhong Li; Hao Xu; Jin-Kuang Lin; Wen-Ge Liu
Journal:  Orthop Surg       Date:  2022-08-26       Impact factor: 2.279

10.  Allogeneic red blood cell transfusion is an independent risk factor for 1-year mortality in elderly patients undergoing femoral neck fracture surgery: Retrospective study.

Authors:  Hyeon Ju Shin; Jong Hun Kim; Seung-Beom Han; Jong Hoon Park; Woo Young Jang
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.